BMI was invented in the 1830s by a mathematician — not a doctor. It misclassifies athletes, varies by ethnicity, and ignores where your body stores fat. Here are the metrics that actually tell you whether treatment makes sense.
BMI (Body Mass Index) remains the standard eligibility screening tool for weight loss medication: BMI ≥30 qualifies, or BMI ≥27 with a weight-related health condition. But BMI is a crude measurement that divides weight by height squared and ignores everything else — muscle mass, fat distribution, bone density, metabolic health, and ethnic variation.
The result: BMI misclassifies roughly 30% of people. It labels muscular athletes as "obese" while clearing metabolically unhealthy people at "normal" weight. A bodybuilder at 5'10" and 210 lbs has a BMI of 30.1 — technically obese — despite carrying 10% body fat. Meanwhile, a sedentary person at 5'10" and 165 lbs (BMI 23.7, "normal") may have 30% body fat, insulin resistance, and elevated cardiovascular risk.
The BRI incorporates waist circumference and height to estimate body roundness — a better proxy for central (visceral) fat, which drives metabolic disease. Unlike BMI, BRI distinguishes between people who carry fat around their midsection (higher health risk) and those who carry it in their hips and legs (lower risk). A BRI above 6.9 is associated with significantly elevated mortality risk, regardless of BMI.
Simple, free, and more predictive of cardiovascular risk than BMI. Measure your waist at its narrowest point and your hips at their widest. A ratio above 0.90 for men or 0.85 for women indicates elevated health risk. This captures the "apple vs. pear" body shape distinction that BMI completely misses.
Even simpler: waist circumference above 40 inches (men) or 35 inches (women) indicates elevated visceral fat and metabolic risk — regardless of your BMI. The WHO and NHLBI use these cutoffs as independent risk factors for cardiovascular disease, type 2 diabetes, and metabolic syndrome.
The gold standard for measuring body fat percentage, lean mass, and bone density. DEXA (Dual-energy X-ray Absorptiometry) costs $50–150 at most imaging centers. It tells you exactly how much of your body weight is fat, muscle, and bone — and where the fat is located. For tracking weight loss quality (are you losing fat or muscle?), DEXA is irreplaceable.
Blood work tells you more about your health risk than any body measurement. A comprehensive metabolic panel — fasting glucose, HbA1c, lipid panel (LDL, HDL, triglycerides), blood pressure, liver enzymes, and inflammatory markers (hsCRP) — identifies whether excess weight is producing metabolic damage, regardless of BMI. Some providers use these markers alongside (or instead of) BMI to determine treatment eligibility.
| Metric | What It Measures | Cost | Better Than BMI? |
|---|---|---|---|
| BMI | Weight ÷ height² | Free | Baseline only |
| BRI | Body roundness (waist + height) | Free | Yes — captures visceral fat |
| Waist-to-Hip Ratio | Fat distribution | Free | Yes — cardiovascular risk |
| Waist Circumference | Central fat | Free | Yes — metabolic risk |
| DEXA Scan | Body composition | $50–150 | Yes — gold standard |
| Metabolic Panel | Blood markers | $50–200 | Yes — actual health risk |
BMI is still what your insurance company uses for eligibility. If your BMI qualifies you (≥30 or ≥27 with comorbidities), that's the number that matters for access. But don't let a "normal" BMI stop you from seeking evaluation if you have elevated waist circumference, metabolic markers, or a family history of obesity-related disease. A comprehensive provider will look beyond the number on the scale.
Licensed providers who evaluate your complete health picture. Available across all 50 states with transparent pricing.
Book an Evaluation →Thorough telehealth consultations that look at the full picture — not just a BMI number.
Get Started →